Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) Treatment

NCT02873936 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

449

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Filgotinib
DRUG: Placebo to match filgotinib
DRUG: csDMARDs

Sponsor

Gilead Sciences

Collaborators

[object Object]